NASDAQ: CSBR - Champions Oncology, Inc.

Rentabilität für sechs Monate: +147.41%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Champions Oncology, Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Champions Oncology, Inc.

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

weitere details
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2003-01-10
ISIN US15870P3073
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.championsoncology.com
Цена ао 10.26
Preisänderung pro Tag: +0.5871% (10.22)
Preisänderung pro Woche: +1.08% (10.17)
Preisänderung pro Monat: -7.3% (11.09)
Preisänderung über 3 Monate: +127.43% (4.52)
Preisänderung über sechs Monate: +147.41% (4.155)
Preisänderung pro Jahr: +84.23% (5.58)
Preisänderung über 3 Jahre: +32.47% (7.76)
Preisänderung über 5 Jahre: +25.67% (8.18)
Preisänderung über 10 Jahre: 0% (10.28)
Preisänderung seit Jahresbeginn: +19.95% (8.57)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 1.33 9
P/BV -35.03 0
P/E 197.15 1
EV/EBITDA -14.14 0
Gesamt: 4.63

Effizienz

Name Bedeutung Grad
ROA, % -24.08 0
ROE, % -532.46 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -1.47 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 56.25 7
Rentabilität Ebitda, % 1540.91 10
Rentabilität EPS, % 221.98 10
Gesamt: 7.4
Weitere Details

Institutionen Volumen Aktie, %
Battery Management Corp. 2421673 17.81
NEA Management Company, LLC 1713720 12.61
Tocqueville Asset Management L.P. 684578 5.04
Renaissance Technologies, LLC 124791 0.92
Blackrock Inc. 116097 0.85
Vanguard Group Inc 82837 0.61
Essex Investment Management Co LLC 77200 0.57
Ameriprise Financial, Inc. 75044 0.55
Geode Capital Management, LLC 61349 0.45
Northern Trust Corporation 44917 0.33

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
iShares Micro-Cap ETF 0.00839 17.09 1.54048



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (59 Jahre)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (56 Jahre)
Mr. Brady Davis President N/A 1969 (56 Jahre)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

Adresse: United States, Hackensack. NJ, One University Plaza - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.championsoncology.com